1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Canada Pharmaceuticals and Healthcare Report Q4 2014

Canada Pharmaceuticals and Healthcare Report Q4 2014

  • September 2014
  • -
  • Business Monitor International
  • -
  • 122 pages

Includes 3 FREE quarterly updates

BMI View:
Canada will continue to attract pharmaceutical companies to launch innovative medicines due to the hospitable business environment, improving healthcare coverage and broader drug reimbursement lists. The regulatory authority also encourages pharmaceutical companies to invest in research and development. However, cost containment policies in the public healthcare sector will continue to put pressure on Canada's medicine prices.

Headline Expenditure Projections
- Pharmaceuticals: CAD25.6bn (USD24.9bn) in 2013 to CAD25.9bn (USD22.5bn) in 2014; +0.8% in local currency terms and -9.7% in US dollar terms. Forecast unchanged from Q314.

Table Of Contents

Canada Pharmaceuticals and Healthcare Report Q4 2014
BMI Industry View ... 7
SWOT 9
Political . 11
Economic ... 12
Industry Forecast .. 13
Pharmaceutical Market Forecast 13
Table: Pharmaceutical Sales, Historical Data And Forecasts (Canada 2010-2018)................ . . 14
Healthcare Market Forecast .. 15
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Canada 2010-2018).............. 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Canada 2010-2018).......... . . 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Canada 2010-2018)...........17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Canada 2010-2018)............ . . 19
Patented Drug Market Forecast . 20
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Canada 2010-2018)............. . . 21
Generic Drug Market Forecast .. 22
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Canada 2010-2018)............. . . 25
OTC Medicine Market Forecast . 26
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Canada 2010-2018).......27
Pharmaceutical Trade Forecast . 28
Table: Pharmaceutical Trade Data And Forecasts (Canada 2012-2018)................... . 29
Table: Pharmaceutical Trade Data And Forecasts local currency (Canada 2012-2018)............... . 29
Other Healthcare Data . 30
Table: Health Expenditure By Sector And Type, 2009 (CADmn)..................... . . 30
Table: Pharmacists By Type, Province And Territory, 2011...................... . . 31
Table: Active Physicians, 2005-2009............................ . . 32
Key Risks To BMI's Forecast Scenario . 33
Macroeconomic Forecasts ... 34
Table: Canada - Economic Activity............................. . 36
Industry Risk Reward Ratings .. 42
Americas Risk/Reward Ratings ... 42
Canada Risk/Reward Ratings . 48
Rewards ... 48
Risks 49
Market Overview ... 50
Industry Trends And Developments 51
Epidemiology 51
Non-Communicable Diseases ... 52
Healthcare Sector .. 53
Table: Sustainability Of Public Health Expenditure And Pharmaceutical Approval Indicators............. . . 55
Research and Development 58
Biotechnology ... 60
BioSimilar Medicines .. 61
Personalised Medicine 62
Regulatory Development .. 64
Pharmacovigilance . 65
Intellectual Property Regime 68
Pricing Regime .. 71
Reimbursement Regime ... 72
Recent Developments .. 75
Competitive Landscape 79
Pharmaceutical Industry . 79
Table: Top 20 Pharmaceutical Companies According To Market Capitalisation On The Canadian Stock Exchange.......79
Pharmaceutical Re-import Policy .. 80
Recent Pharmaceutical Company Developments .. 82
Pharmaceutical Retail . 83
Company Profile 85
Apotex ... 85
Valeant .. 88
Pfizer 95
GlaxoSmithKline . 99
Sanofi .. 103
Merck and Co .. 106
Novartis ... 109
Demographic Forecast ... 112
Demographic Outlook 112
Table: Canada's Population By Age Group, 1990-2020 ('000).....................113
Table: Canada's Population By Age Group, 1990-2020 (% of total).................... . 114
Table: Canada's Key Population Ratios, 1990-2020........................ . 115
Table: Canada's Rural And Urban Population, 1990-2020......................115
Glossary ... 116
Methodology 118
Pharmaceutical Expenditure Forecast Model 118
Healthcare Expenditure Forecast Model ... 118
Notes On Methodology .. 119
Risk/Reward Ratings Methodology .. 120
Ratings Overview . 121
Table: Pharmaceutical Risk/Reward Ratings Indicators....................... . . 121
Indicator Weightings 122

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7 000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

IMS World Review Executive™ 2016

IMS World Review Executive™ 2016

  • $ 6 860
  • Industry report
  • July 2016
  • by IMS Health

IMS World Review ExecutiveTM 2016 provides essential insights into worldwide sales of the pharmaceutical market, interlocking market trends and sales analysis from 2011 to 2015, including the breakdown ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.